Recyclable, heterogeneous bimetallic ruthenium/molybdenum catalysts, formed in situ from triruthenium dodecacarbonyl [Ru3(CO)12] and molybdenum hexacarbonyl [Mo(CO)6], are effective for the selective liquid phase hydrogenation of cyclohexylcarboxamide (CyCONH2) to cyclohexanemethylamine (CyCH2NH2), with no secondary or tertiary amine by‐product formation. Variation of Mo:Ru composition reveals both synergistic and poisoning effects, with the optimum combination of conversion and selectivity at ca. 0.5, and total inhibition of catalysis evident at ≥1. Good amide conversions are noted within the reaction condition regimes 20–100 bar hydrogen and 145–160 °C. The order of reactivity of these catalysts towards reduction of different amide functional groups is primary>tertiary≫secondary. In situ HP‐FT‐IR spectroscopy confirms that catalyst genesis occurs during an induction period associated with decomposition of the organometallic precursors. Ex situ characterisation, using XRD, XPS and EDX‐STEM, for active Mo:Ru compositions, has provided evidence for intimately mixed ca. 2.5–4 nm particles that contain metallic ruthenium, and molybdenum (in several oxidation states, including zero).
No takes yet. Share an insight, caveat, or question.
Beamson et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: